Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Does natalizumab therapy worsen neuromyelitis optica?
The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
Peripheral tolerance and autoimmunity: lessons from in vivo imaging.
Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.
Stem cell therapy for central nerve system injuries: glial cells hold the key.
PERK Dependent Activation of JAK1 and STAT3 Contributes to ER Stress Induced Inflammation.
Cognitive rehabilitation in Multiple sclerosis.
Assessment and classification of early stage multiple sclerosis with inertial sensors: comparison against clinical measures of disease state.
Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
Bilateral Vision Loss Responsive to Corticosteroids.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Immune-mediated disorders among women carriers of fragile X premutation alleles.
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Encephalitis followed by optic neuritis: a case report and review of literature.
Role of autophagy in the pathogenesis of multiple sclerosis.
Managed care aspects of managing multiple sclerosis.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol

Pages